pharmaphorum

JUNE 24, 2022

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. ” The post Biogen and Happify partner on digital support for MS patients appeared first on. .

Patients 40

Patients Prescription Biopharma Insurance 40

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Let’s talk about the current economic uncertainty and what it means for pharma marketers. What does this mean for pharma marketers? Risks to forecasts.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Let’s talk about the current economic uncertainty and what it means for pharma marketers. What does this mean for pharma marketers? Risks to forecasts.

Marketing 52

Marketing Pharma Patients Insurance 52

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 97

Marketing Sales Medical Patients 97

pharmaphorum

OCTOBER 24, 2022

A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected. Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 Since then is has also been approved to treat pain associated with endometriosis. Pfizer agreed a $4.2

Biopharma 68

Biopharma Pharma Marketing Prescription 68

pharmaphorum

SEPTEMBER 26, 2022

Brown isn’t a newbie to the pharma sector, however, having previously held roles at UK drugmaker AstraZeneca and medical device player Smith & Nephew, as well as serving as a non-executive director and audit chair at Roche, before stepping down from that role today. Julie Brown. billion and $1.9 billion, respectively.

Management 52

Management Pharma Biopharma Prescription 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. The biggest impacts are likely to be felt by patients with PDPs that use coinsurance, which most plans do for specialty drugs. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

NOVEMBER 4, 2022

Any reduced availability of medicines has a significant impact on patient care. As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The CMO solution.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. FirstWord PHARMA.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Clarivate

NOVEMBER 23, 2021

Learnings from bringing clinical trial management in-house, and how to modernize your approach to patient-first trials with advanced data science, real-world data and other patient intelligence. Clearly, making sure that we’ve got the right patients and principal investigators is still a challenge.

Patients 52

Patients Recruitment Management Healthcare 52

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street.

FDA 52

FDA Prescription Medicine Biopharma 52

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. RxPass offers more than 50 select prescriptions at no additional cost for $5 per month.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. This strategy is reacting to the cost challenges patients face and is an “affordable solution for patients who are uninsured, underinsured, or recently separated from Medicaid coverage,” said Coherus chief business officer Chris Slavinsky in a statement.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. R&D efficiency is more critical than ever.

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Clarify Health

MAY 19, 2020

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Clarivate

FEBRUARY 28, 2023

LHON mutation rate variability affects therapeutic efficacy Most LHON patients carry one of three pathogenic mitochondrial DNA mutations (11778G>A [ND4], 14484T>C [ND6] and 3460G>A [ND1]) known as primary LHON mutations. We identified patients with an LHON diagnosis using ICD-10 and ICD-9 codes H47.2 The Clarivate U.S.

Prescription 98

Prescription Patients Pharmacology Healthcare 98

Clarivate

MARCH 17, 2022

Lack of information based on clinical data can mean providers and patients decide against treating underlying conditions, “which in some cases may result in more harm” to the parent and the fetus than if they had received treatment.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10